Imugene surges as drug advances to human trials
MELBOURNE: Shares in Imugene – an ASX-listed biotech looking to crush cancer using a patient’s
MELBOURNE: Shares in Imugene – an ASX-listed biotech looking to crush cancer using a patient’s